Article
Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population.
The pharmacogenomics journal - 1 Apr 2021
Munisamy Murali, Munisamy Srinivasan, Kumar Julka Pramod, Jose Anmi, Thomas Levin, Baburaj Gayathri, Subbiah Vivekanandhan
Abstract excerpt
Temozolomide (TMZ), an alkylating agent with a broad-spectrum antitumor activity, ability to cross blood-brain barrier (BBB), shown to be effective against malignant glioma. This study aims to investigate the effect of 1236C>T (rs1128503) single-nucleotide gene polymorphisms of ABCB1 (MDR1) in north-Indian patients diagnosed with glioma undergoing TMZ-based chemoradiotherapy. Genotyping was performed in 100...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
